Notably, the results showed that in vitro, CAR-T cells could effectively lyse either CLL-like MEC-1 cells or primary CLL cells and release cytokines such as interferon-γ (IFN-γ) without serious toxicity for normal B cells. This evidence concerns the gene IFNG and B-cell chronic lymphocytic leukemia.